Scientists Testing Inhaler Protection Against the Coronavirus

September 16, 2020

As the world waits for the development of an immunization to give people immunity against COVID-19, scientists at University of California in San Francisco are looking to test an aerosol which they believe can protect users from the coronavirus.

Users could self-administer the aerosol, dubbed “AeroNabs,” through a nasal spray or inhaler. Used once a day, it could provide protection against SARS-CoV-2 until a vaccine becomes available. The research team is in active discussions with commercial partners to ramp up manufacturing and clinical testing of AeroNabs, which they describe as “molecular personal protective equipment (PPE).”

The coronavirus invades hosts through its spikes. These spikes can switch from a closed, inactive state to an open, active state, during which it can attach to human cells that line the lung and airway. The aerosol works by disabling the spikes, thereby preventing the virus from infecting hosts.

Latest Articles

Modernizing Facility Security With Drones
February 9, 2026 Dennis Crowley

Modernizing Facility Security With Drones

February 6, 2026 Rosie Rangel

Building a Bridge for the Hispanic Cleaning Community

February 4, 2026 Jeff Cross

Closing the Deal: How the Right Question Puts You Back in Control

Sponsored Articles

US 31DC XC2 12V Battery
January 30, 2026

US 31DC XC2 12V Battery

January 30, 2026

US 305N XC2 6V Battery

January 30, 2026

Built for Daily Cleaning Demands

Recent News

small business loan, small business

Small Business Administration Bars Noncitizens From Loans

Norovirus Delays Winter Olympics Ice Hockey Match

Illinois Joins the WHO’s Global Outbreak Response Network